“We’ve been very interested in familial breast cancer and the contribution of genes like BRCA1 and BRCA2 that predispose families to breast cancer. We’re very interested in looking at the genetic basis of breast cancer in young women. As a result of that investigation, we’re hoping to develop better tools and better methods to manage triple-negative breast cancer, because that’s what we see to be over-represented in young African American women and women with BRCA1 mutations.”